Evidence map›Paper›PMID 26437418›Full record

ReviewMarine drugs2015

Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer.

Elena Talero, Sofía García-Mauriño, Javier Ávila-Román, Azahara Rodríguez-Luna, Antonio Alcaide, Virginia Motilva

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 239 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elena TaleroDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, Seville 41012, Spain. etalero@us.es.
Sofía García-MauriñoDepartment of Plant Biology and Ecology, Faculty of Biology, University of Seville, Seville 41012, Spain. sgarma@us.es.
Javier Ávila-RománDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, Seville 41012, Spain. javieravila@us.es.
Azahara Rodríguez-LunaDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, Seville 41012, Spain. arodriguez53@us.es.
Antonio AlcaideDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, Seville 41012, Spain. aalcaide@us.es.
Virginia MotilvaDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, Seville 41012, Spain. motilva@us.es.
Universidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The risk of onset of cancer is influenced by poorly controlled chronic inflammatory processes. Inflammatory diseases related to cancer development include inflammatory bowel disease, which can lead to colon cancer, or actinic keratosis, associated with chronic exposure to ultraviolet light, which can progress to squamous cell carcinoma. Chronic inflammatory states expose these patients to a number of signals with tumorigenic effects, including nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases (MAPK) activation, pro-inflammatory cytokines and prostaglandins release and ROS production. In addition, the participation of inflammasomes, autophagy and sirtuins has been demonstrated in pathological processes such as inflammation and cancer. Chemoprevention consists in the use of drugs, vitamins, or nutritional supplements to reduce the risk of developing or having a recurrence of cancer. Numerous in vitro and animal studies have established the potential colon and skin cancer chemopreventive properties of substances from marine environment, including microalgae species and their products (carotenoids, fatty acids, glycolipids, polysaccharides and proteins). This review summarizes the main mechanisms of actions of these compounds in the chemoprevention of these cancers. These actions include suppression of cell proliferation, induction of apoptosis, stimulation of antimetastatic and antiangiogenic responses and increased antioxidant and anti-inflammatory activity.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsApoptosisCell ProliferationChemopreventionColonic NeoplasmsHumansInflammationMicroalgaeSkin NeoplasmsAnti-Inflammatory AgentsAntioxidantschemopreventionchronic inflammationcolon cancermicroalgaeskin cancer

Identifiers

PMID26437418
PMCPMC4626684
OpenAlexW2155167868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.